Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Macrogenics (MGNX) Gross Margin (2020 - 2025)

Macrogenics (MGNX) has disclosed Gross Margin for 6 consecutive years, with 100.0% as the latest value for Q4 2025.

  • On a quarterly basis, Gross Margin rose 58.0% to 100.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 100.0%, a 1885.0% decrease, with the full-year FY2025 number at 100.0%, up 56.0% from a year prior.
  • Gross Margin was 100.0% for Q4 2025 at Macrogenics, roughly flat from 100.0% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 100.0% in Q1 2025 to a low of 89.37% in Q3 2021.
  • A 5-year average of 97.91% and a median of 99.42% in 2024 define the central range for Gross Margin.
  • Peak YoY movement for Gross Margin: plummeted -1063bps in 2021, then soared 654bps in 2022.
  • Macrogenics' Gross Margin stood at 93.31% in 2021, then increased by 7bps to 99.84% in 2022, then dropped by -1bps to 98.48% in 2023, then rose by 1bps to 99.42% in 2024, then grew by 1bps to 100.0% in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Gross Margin are 100.0% (Q4 2025), 100.0% (Q3 2025), and 100.0% (Q2 2025).